Santhera Pharmaceuticals Holding AG at Annual General Meeting held on 30 June 2022, shareholders elected Thomas Meier, PhD, as Chairman of the Board of Directors. As members of the Compensation Committee, the shareholders confirmed Patrick Vink and elected Thomas Meier, PhD. Elmar Schnee, Chairman of the Board and member of the Compensation Committee of Santhera since 2017, did not stand for re-election (as per amendment to the AGM invite).